ReleaseU.S. Department of Justice

Maryland Long Term Care Pharmacy Pays $5.3M to Settle Allegations of Billing for Drugs Without Valid Prescriptions

U.S. Department of Justice published "Maryland Long Term Care Pharmacy Pays $5.3M to Settle Allegations of Billing for Drugs Without Valid Prescriptions" at 2026-09-17 12:00 UTC. First seen on Kresmion 2026-09-17 17:47 UTC, 5 h after publication.

As of 2026-09-17 12:00 UTC. Source: www.justice.gov. Method and limitations.

The record

Publisher: U.S. Department of Justice
Source: U.S. Department of Justice
Kind: Release
Jurisdiction: United States
Topics: Enforcement
Importance: Notable, the middle of three tiers Kresmion sets by fixed rules from the source's own fields
Published (source time): 2026-09-17 12:00 UTC
First seen on Kresmion: 2026-09-17 17:47 UTC, 5 h after publication

The original

Open the original on www.justice.gov

Link checked 2026-10-27: available.

Source: U.S. Department of Justice. U.S. Government work.

The publisher's summary

Remedi SeniorCare Holding Corporation (Remedi), headquartered in Towson, Maryland, has agreed to pay over $5.3 million to the United States to resolve allegations that it violated the False Claims Act (FCA) by billing the Medicare and Medicaid programs for prescription drugs despite lacking valid prescriptions. The settlement is based on Remedi’s ability to pay and will be paid over time.

The publisher's words, as published.

Cite this data

Kresmion stores the publisher's own title, the source's time and the time Kresmion first saw it, and checks the primary link 1, 7 and 30 days after first sight. Kresmion adds no text of its own.

Upstream: U.S. Department of Justice

Kresmion, "Maryland Long Term Care Pharmacy Pays $5.3M to Settle Allegations of Billing for Drugs Without Valid Prescriptions", data as of 2026-09-17, https://kresmion.com/record/4096. Upstream data: U.S. Department of Justice.

Link to this data (HTML):

<a href="https://kresmion.com/record/4096">Maryland Long Term Care Pharmacy Pays $5.3M to Settle Allegations of Billing for Drugs Without Valid Prescriptions (Kresmion)</a>